Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000015

Chief Scientific Officer acquired 28,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mahaney Paige · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Grant or award : show line 1 in the form +28,200 105,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +42,400 42,400 D
Loading xslF345X05/wk-form4_1739915672.xml…